Jan Endell

This inventor holds 14 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 11 EPO patents. Top assignees: Morphosys Ag, Incyte Corporation. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Endell. Retrieved from https://idiyas.com/inventor/jan-endell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 9)

% Patents Active = 92.9

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 30(Granted Patents)

Company Filing History:

Years Active: 2014-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747292 - ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS (2026-09-29),

2. 12631639 - METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS (2026-05-19),

3. 12491244 - PHARMACEUTICAL COMBINATIONS FOR TREATING TUMOR COMPRISING ANTI-CD19 ANTIBODY AND NATURAL KILLER CELL (2025-12-09),

4. 12358983 - Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof (2025-07-15),

5. 12194095 - Combinations and uses thereof (2025-01-14),

6. 11591406 - Treatment for multiple myeloma (MM) (2023-02-28),

7. 11224654 - Combinations and uses thereof (2022-01-18),

8. 10617691 - Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof (2020-04-14),

9. 10533057 - Treatment for multiple myeloma (MM) (2020-01-14),

10. 10308722 - Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide (2019-06-04),

11. 9765152 - Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib (2017-09-19),

12. 9579378 - Combinations and uses thereof (2017-02-28),

13. 9289490 - Combinations and uses thereof (2016-03-22),

14. 8877899 - Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL (2014-11-04),

Title: The Innovative Mind of Jan Endell

Introduction: Jan Endell, a visionary inventor hailing from Munich, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jan Endell's recent patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable transportation methods.

Career Highlights: With a career spanning over two decades, Jan Endell has established himself as a pioneer in the tech industry, consistently pushing the boundaries of what is possible. His work has revolutionized various sectors, earning him recognition as a leading figure in the world of innovation.

Collaborations: Throughout his career, Jan Endell has collaborated with top research institutions, universities, and forward-thinking companies to bring his ideas to life. His ability to work seamlessly with diverse teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Jan Endell's passion for innovation, coupled with his relentless drive to create a better future through technology, sets him apart as a true trailblazer in the world of inventions. His work continues to inspire and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.